论文部分内容阅读
《“十三五”国家药品安全规划》发布:坚持“最严谨的标准、最严格的监管、最严厉的处罚、最严肃的问责”要实现药品质量进一步提高,分期分批对已上市的药品进行质量和疗效一致性评价。审评审批体系逐步完善,实现按规定时限审评审批。药品监测评价水平要进一步提升,药品定期安全性更新报告评价率达到100%。要提升检查能力,使职业化检查员的数量、素质满足检查需要,加大检查频次。
“” Thirteen Five “National Drug Safety Planning” release: adhere to the “most stringent standards, the most stringent regulation, the most severe penalties, the most serious accountability” To achieve further improvement of the quality of medicines, installments in batches Has been listed on the consistency of quality and efficacy of the drug evaluation. Review and approval system gradually improved, according to the time limit for review and approval. Drug monitoring and evaluation to further improve the regular report of drug safety update rate of 100%. To improve the inspection capabilities, so that the number of professional inspectors to meet the inspection needs to improve the inspection frequency.